Aniline

Aniline

SCHEMBL3548033

COc1cc(OCCN2CCOCC2)ccc1N.Nc1ccccc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
RAB9A P51151 1/20 0.54
LTA4H P09960 1/20 0.53
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 1/20 0.51
PTPN1 P18031 1/20 0.50
SYK P43405 1/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
FGFR1 P11362 1/20 0.49
SRC P12931 1/20 0.49
BCHE P06276 1/20 0.48
ACHE P22303 1/20 0.48
PSMB1 P20618 1/20 0.48
PSMB5 P28074 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
PPARG P37231 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29788588 0.93 ALDH1A1 (0.58) NPC1RAB9ALTA4HALDH1A1KDM4E
SCHEMBL375708 0.93 ALDH1A1 (0.58) NPC1RAB9ALTA4HALDH1A1KDM4E
SCHEMBL15938888 0.87 HRH3 (0.60) ALDH1A1KDM4ETSHRSMN1; SMN2NPSR1
SCHEMBL12312257 0.83 ALDH1A1 (0.58) NPC1RAB9ALTA4HALDH1A1KDM4E
SCHEMBL1964263 0.81 LTA4H (0.59) LTA4HALDH1A1KDM4ESMN1; SMN2PSMB1
SCHEMBL3315480 0.80 DRD3 (0.52) LTA4HALDH1A1SMN1; SMN2
SCHEMBL2204177 0.80 MEN1 (0.52) LTA4HALDH1A1KDM4EMEN1KMT2A
SCHEMBL1962645 0.80 LTA4H (0.58) LTA4HKDM4EPSMB1PSMB5
SCHEMBL1911850 0.79 NPC1 (0.66) NPC1RAB9AALDH1A1KDM4ESYK
SCHEMBL3383766 0.79 ALDH1A1 (0.65) NPC1RAB9ALTA4HALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709471-B2 Compounds ASTRAZENECA AB (SE) 2010-05-04 US disclosed
US-20080009482-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2008-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009482-A1 NOVEL COMPOUNDS CYP11B2, CYP11B1, CYP46A1 NPC1 13/4885RAB9A 1172/4885LTA4H 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.